デフォルト表紙
市場調査レポート
商品コード
1446543

臨床栄養市場の市場規模、シェア、動向分析レポート:製品別、適応症別、販売チャネル別、地域別、セグメント予測、2024年~2030年

Clinical Nutrition Market Size, Share & Trends Analysis Report By Product (Oral Clinical, Parenteral), By Indication (Alzheimer's, Nutrition Deficiency, Cancer Care), By Sales Channel (Retail, Online), By Region, And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 125 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=159.16円
臨床栄養市場の市場規模、シェア、動向分析レポート:製品別、適応症別、販売チャネル別、地域別、セグメント予測、2024年~2030年
出版日: 2024年02月22日
発行: Grand View Research
ページ情報: 英文 125 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床栄養市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界の臨床栄養市場規模は2030年までに441億7,000万米ドルに達し、CAGR 5.34%で成長すると予測されています。

高齢者人口の増加と慢性疾患の有病率の増加、個別化・標的化ソリューションの革新、ヘルスケアインフラの進歩などが市場成長を促進する要因となっています。

世界保健機関(WHO)によると、60歳以上の世界人口は2020年の約10億人から2030年には約14億人に急増し、2050年には約21億人に倍増すると予測されています。近年、重篤な健康状態と診断される高齢者の数が大幅に増加しています。さらに、米国国立生物工学情報センター(NCBI)が発表した様々な研究によると、65歳以上の高齢者は、アルツハイマー病、パーキンソン病、その他の神経疾患などの慢性疾患を発症するリスクが高いことが示されています。例えば、アルツハイマー病協会の報告によると、アルツハイマー病に罹患している550万人のアメリカ人のうち、推定530万人が65歳以上です。

その結果、ヘルスケア専門家は高齢者への臨床栄養介入の最適化にますます注力するようになり、市場の成長を後押ししています。加えて、老化プロセスは免疫系を低下させ、感染症に対する脆弱性を高め、必要不可欠な身体機能に影響を及ぼします。骨髄異形成症候群は、赤血球の不足や未熟化をもたらす血球産生低下を特徴とし、貧血に関連する感染症や合併症のリスクを高め、結果として経腸栄養剤の需要を押し上げています。

対象疾患の罹患率の上昇と医薬品開発の進歩は、疾患特異的処方の需要を促進すると予想されます。臨床栄養は、嚢胞性線維症、がんなどの疾患の個別化治療に広く使用されています。Nestleなどの著名な企業は、うつ病用のDeplinや糖尿病用のMetanxなどの個別化臨床栄養製品を専門としています。デプリンは非処方用葉酸とは異なり、すでに活性化された葉酸を含んでいます。特筆すべきは、うつ病患者の7割は葉酸の活性化能力が低いため、様々な非代謝性患者向けにデプリンのような医療用食品の需要が高まっていることです。これらの要因は、治療の効果を高め、医療全体の質を向上させるのに役立つことで、臨床栄養の需要を促進すると考えられる

COVID-19の大流行により、ヘルスケアサービスの負担が増加し、重症患者の治療感受性が高まっています。COVID-19陽性と判定された患者は、しばしば免疫力が低下し、呼吸器系やその他のシステムに障害をきたします。例えば、ElsevierのPublic Health Emergency Collectionの出版物で強調されているように、重症のCOVID-19患者の半数近くが運動機能低下などの消化器合併症を呈しています。加えて、患者は他の様々な腹部の問題を経験し、世界および国レベルで臨床栄養の採用が増加しました。

さらに、パンデミック中に生じた栄養不良の問題を経験した患者に対する非経口栄養剤の利用を正当化する研究が数多く行われ、市場の拡大に貢献しました。例えば、Journal of the Academy of Nutrition and Dieteticsに掲載された論文によると、COVID-19治療のためにICUに収容された患者は急性栄養失調に苦しんでいた。このため、パンデミックの間、市場では非経口栄養製品の使用量が増加しました。

さらに、市場の主要企業がその地位を強化するために行ったさまざまな取り組みが、市場の成長にプラスの影響を与えています。例えば、2023年3月、ダノンはポーランドを拠点とし、在宅患者へのケアサービスの提供を専門とするProMedica社を買収しました。同様に、2023年1月、Nestle社は米国ウィスコンシン州オークレアにある製造施設を拡張するため、4,300万米ドルを投資すると発表しました。

臨床栄養市場レポートハイライト

  • タイプ別に、市場は非経口栄養剤、経口栄養剤、経腸栄養剤に区分されます。経口栄養剤セグメントは2023年に53.3%の最大収益シェアを占めました。成人人口の栄養不良の有病率の上昇、肥満の事例の増加、がん、糖尿病などの慢性疾患の増加が市場成長を後押しする主な要因です。非経口栄養セグメントは、予測期間中に最も速い速度で成長すると予測されています。
  • 用途別では、がん治療分野が2023年に18.4%の収益シェアで市場を独占したが、吸収不良分野は予測期間を通じて大幅な成長を示すと予測されています。
  • 機関販売チャネルが極めて重要な役割を果たし、2023年に45.8%の最大市場シェアを占めています。一方、オンラインチャネルはCAGRが6.15%と最も早いと予測されています。
  • 2023年には、北米が32.62%の最大の売上シェアを占め、アジア太平洋はヘルスケアインフラの改善、医療費の増加、早産の多発、一人当たり所得の増加により、最も速い成長が見込まれます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 臨床栄養市場の変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 臨床栄養市場分析ツール
    • ポーターの分析
    • PESTEL分析

第4章 臨床栄養市場:製品推定・動向分析

  • 定義と範囲
  • 製品市場シェア分析、2023年および2030年
  • セグメントダッシュボード
  • 臨床栄養市場:製品別、2018年から2030年
  • 経口臨床栄養学
  • 経腸栄養剤
  • 非経口栄養学

第5章 臨床栄養市場:推定・動向分析

  • 定義と範囲
  • 適応症市場シェア分析、2023年および2030年
  • セグメントダッシュボード
  • 臨床栄養市場:適応別、2018年から2030年
  • アルツハイマー病
  • 栄養不足
  • がん治療
  • 糖尿病
  • 慢性腎臓病
  • 孤児病
  • 嚥下障害
  • 疼痛管理
  • 吸収不良/消化器疾患/下痢
  • その他

第6章 臨床栄養市場:販売チャネルの予測と動向分析

  • 定義と範囲
  • 販売チャネル市場シェア分析、2023年および2030年
  • セグメントダッシュボード
  • 臨床栄養市場:販売チャネル別、2018年から2030年
  • オンライン販売チャネル
  • 小売販売チャネル
  • 機関向け販売チャネル

第7章 臨床栄養市場:国、製品、適応症、販売チャネル別の地域推定・動向分析

  • 定義と範囲
  • 地域市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 地域市場のスナップショット
  • SWOT分析
  • 臨床栄養市場シェア、地域別、2023年および2030年、10億米ドル <
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • デンマーク
    • スウェーデン
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • UAE
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業の分類
  • 企業の市場シェア分析
  • 企業ヒートマップ分析
  • 戦略マッピング
    • 拡大
    • 合併と買収
    • パートナーシップとコラボレーション
    • 新製品の発売
    • 研究開発
  • 企業プロファイル
    • Abbott Nutrition
    • Pfizer Inc.
    • Bayer AG
    • Nestle.
    • Baxter International Inc.
    • Otsuka Holdings Co., Ltd.
    • Mead Johnson &Company, LLC
    • Danone(Nutricia)
    • Victus, Inc.
    • Fresenius Kabi
    • Meiji Holdings. Co., Ltd.
    • AbbVie(Allergan)
    • Baxter
    • Grifols, SA
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America Clinical nutrition market estimates and forecasts,by product, 2018 - 2030 (USD Billion)
  • Table 4 North America Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 5 North America Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 6 U.S. Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 7 U.S. Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 8 U.S. Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 9 Canada Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 10 Canada Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 11 Canada Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 12 Europe Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 13 Europe Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 14 Europe Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 15 UK Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 16 UK Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 17 UK Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 18 Germany Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 19 Germany Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 20 Germany Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 21 France Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 22 France Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 23 France Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 24 Italy Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 25 Italy Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 26 Italy Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 27 Spain Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 28 Spain Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 29 Spain Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 30 Sweden Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 31 Sweden Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 32 Sweden Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 33 Denmark Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 34 Denmark Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 35 Denmark Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 36 Norway Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 37 Norway Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 38 Norway Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 39 Asia Pacific Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 40 Asia Pacific Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 41 Asia Pacific Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 42 Japan Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 43 Japan Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 44 Japan Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 45 China Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 46 China Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 47 China Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 48 India Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 49 India Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 50 India Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 51 Australia Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 52 Australia Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 53 Australia Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 54 South Korea Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 55 South Korea Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 56 South Korea Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 57 Thailand Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 58 Thailand Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 59 Thailand Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 60 Latin America Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 61 Latin America Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 62 Latin America Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 63 Brazil Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 64 Brazil Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 65 Brazil Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 66 Mexico Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 67 Mexico Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 68 Mexico Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 69 Argentina Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 70 Argentina Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 71 Argentina Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 72 MEA Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 73 MEA Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 74 MEA Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 75 South Africa Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 76 South Africa Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 77 South Africa Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 78 Saudi Arabia Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 79 Saudi Arabia Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 80 Saudi Arabia Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 81 UAE Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 82 UAE Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 83 UAE Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
  • Table 84 Kuwait Clinical nutrition market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 85 Kuwait Clinical nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
  • Table 86 Kuwait Clinical nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 List of Figures
  • Fig. 2 Clinical Nutrition Market Segmentation
  • Fig. 3 Information Procurement
  • Fig. 4 Data Analysis Models
  • Fig. 5 Market Formulation and Validation
  • Fig. 6 Data Validating & Publishing
  • Fig. 7 Market Snapshot
  • Fig. 8 Segment Snapshot (1/2)
  • Fig. 9 Segment Snapshot (2/2)
  • Fig. 10 Competitive Landscape Snapshot
  • Fig. 11 Clinical Nutrition - Market Size and Growth Prospects (USD Billion)
  • Fig. 12 Clinical Nutrition Market: Industry Value Chain Analysis
  • Fig. 13 Clinical Nutrition Market: Market Dynamics
  • Fig. 14 Clinical Nutrition Market: PORTER's Analysis
  • Fig. 15 Clinical Nutrition Market: PESTEL Analysis
  • Fig. 16 Clinical Nutrition Market Share by Product 2023 & 2030 (USD Billion)
  • Fig. 17 Clinical Nutrition Market, by product: Market Share, 2023 & 2030
  • Fig. 18 Oral Clinical Nutrition Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 19 Enteral Feeding Formulas Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 20 Standard Formulas Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 21 Disease Specific Formulas Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 22 Parenteral Nutrition Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 23 Parenteral Lipid Emulsion Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Single Dose Amino Acid Solution Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Trace Elements Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Vitamins & Minerals Market Estimates & Forecasts, 2018 - 2030 (USD Million
  • Fig. 27 Clinical Nutrition Market , by Indication: Key Takeaways
  • Fig. 28 Clinical Nutrition Market , by Indication: Market Share, 2023 & 2030
  • Fig. 29 Alzheimer'sMarket Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 30 Nutrition deficiency Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 31 Cancer Care Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 32 Diabetes Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 33 Chronic Kidney Diseases Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 34 Orphan DiseasesMarket Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 35 Dysphagia Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 36 Pain Management Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 37 Malabsorption/GI Disorder/Diarrhea Market Estimates & Forecasts, 2018- 2030 (Revenue, USD Billion)
  • Fig. 38 Others Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 39 Clinical Nutrition Market , by Sales Channel: Key Takeaways
  • Fig. 40 Clinical Nutrition Market , by Sales Channel: Market Share, 2023 & 2030
  • Fig. 41 Online Sales Channel Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 42 Retail Sales Channel Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 43 Institutional Sales Channel Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 44 Clinical Nutrition Market Revenue, by Region, 2023 & 2030, (USD Billion)
  • Fig. 45 Regional Marketplace: Key Takeaways
  • Fig. 46 Regional Marketplace: Key Takeaways
  • Fig. 47 North America Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 48 U.S. Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 49 Canada Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 50 Europe Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 51 U.K. Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030,) (USD Billion)
  • Fig. 52 Germany Clinical Nutrition Market Estimates and Forecasts, (2018 - 2030,) (USD Billion)
  • Fig. 53 France Clinical Nutrition Market Estimates and Forecasts, (2018 - 2030,) (USD Billion)
  • Fig. 54 Asia Pacific Clinical Nutrition Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • Fig. 55 China Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 56 Japan Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 57 India Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 58 South Korea Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 59 Australia Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 60 Latin America Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 61 Brazil Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 62 Mexico Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 63 MEA Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 64 Saudi Arabia Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 65 UAE Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 66 South Africa Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 67 Kuwait Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 68 Key Company Categorization
  • Fig. 69 Company Market Positioning
  • Fig. 70 Key Company Market Share Analysis, 2023
  • Fig. 71 Strategic Framework
目次
Product Code: GVR-4-68040-200-1

Clinical Nutrition Market Growth & Trends:

The global clinical nutrition market size is expected to reach USD 44.17 billion by 2030 and is projected to grow at a CAGR of 5.34 %, according to a new report by Grand View Research, Inc. Growing geriatric population coupled with the increasing prevalence of chronic diseases, innovation in personalized and targeted solutions and advancement in healthcare infrastructure are some of the factors driving the growth of the market.

According to the World Health Organization (WHO), the global population aged 60 years and older is expected to surge from approximately 1 billion in 2020 to about 1.4 billion in 2030, projected to nearly double to approximately 2.1 billion by 2050. Over recent years, there has been a significant rise in the number of older individuals diagnosed with critical health conditions. Furthermore, various studies published by the National Center for Biotechnology Information (NCBI) indicate that individuals aged 65 and above are at an elevated risk of developing chronic diseases, including Alzheimer's, Parkinson's, and other neurological disorders. For example, the Alzheimer's Association reports that out of the 5.5 million Americans affected by Alzheimer's disease, an estimated 5.3 million are 65 years or older.

Consequently, healthcare professionals are increasingly focusing on optimizing clinical nutrition interventions for older adults, thereby boosting market growth. Additionally, the aging process compromises the immune system, heightening vulnerability to infectious diseases and impacting essential bodily functions. Myelodysplastic syndromes, characterized by reduced blood cell production leading to inadequate and/or immature red blood cells, elevate the risk of infection and complications related to anemia, consequently driving demand for enteral feeding formulas.

Rising incidence of targeted diseases and advancements in drug development are expected to drive the demand for disease-specific formulas. Clinical nutrition is extensively used for the personalized treatment of diseases, such as cystic fibrosis, cancer, etc..Prominent companies such as Nestle specialize in personalized clinical nutrition products, which include Deplin for depression and Metanx for diabetes. Deplin is different from nonprescription folic acid, as it contains already-activated folate. It is to be noted that 70% of the patients suffering from depression have a low ability to activate folate, and therefore, the demand for medical foods, such as Deplin, has increased for various nonmetabolizing patients. These factors are likely to drive the demand for clinical nutrition by helping enhance the effectiveness of the treatment and improving the overall quality of medical treatment

The COVID-19 pandemic has led to a rise in the burden on healthcare services and an increase in the treatment sensitivity of critically ill patients. Patients who tested positive for COVID-19 often experience weakened immunity and disruption in respiratory & other systems. For instance, as highlighted in a publication from Elsevier's Public Health Emergency Collection, nearly half of severely ill COVID-19 patients manifest gastrointestinal complications like hypomotility. In addition, patients experienced various other abdominal problems, leading to an increase in the adoption of clinical nutrition at global and country levels.

Furthermore, numerous studies justified the utilization of parenteral nutrition for individuals experiencing malnutrition issues, which arose during the pandemic, thereby contributing to market expansion. For instance, as per an article published in the Journal of the Academy of Nutrition and Dietetics, patients admitted to the ICU for COVID-19 treatment suffered from acute malnourishment. This raised the usage of parenteral nutrition products increased in the market during the pandemic.

Furthermore, various initiatives undertaken by key players in the market to strengthen its position is positively impacting the market growth. For instance, in March 2023, Danone acquired ProMedica, a Poland-based company that specializes in providing care services for patients in their homes. This acquisition is part of Danone's lucrative specialized nutrition market expansion strategy, to strengthen its presence in Poland.Similarly, in January 2023, Nestle announced an investment of USD 43 million to expand its manufacturing facility in Eau Claire, Wisconsin in the U.S.

Clinical Nutrition Market Report Highlights:

  • Based on type, the market is segmented into parenteral nutrition, oral nutrition and enteral feeding formulas. The oral nutrition segment held the largest revenue share of 53.3% in 2023. The rising prevalence of malnutrition among the adult population and the increase in the instances of obesity, rising chronic diseases such as cancer, diabetes are the major factors boosting the market growth. The parenteral nutrition segment is projected to grow at the fastest rate over a forecast period
  • Based on application, the cancer care segment dominated the market with a revenue share of 18.4% in 2023, whereas the malabsorption segment is projected to show substantial growth throughout the forecast period
  • Institutional sales channel played a pivotal role, dominating the sales channel with the largest market share of 45.8% in 2023. On the other hand, online channels are anticipated to exhibit the fastest CAGR of 6.15%
  • In 2023, North America held the largest revenue share of 32.62%, while Asia Pacific is expected to witness the fastest growth due to improving healthcare infrastructure, rising healthcare expenditure, high occurrence of preterm births, and growing per capita income

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Indication Outlook
    • 2.2.3. Sales Channel Outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Nutrition Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising Geriatric Population
      • 3.2.1.2. Growing Prevalence of Chronic Disease
      • 3.2.1.3. Shifting Trends Towards the Consumption of Disease Specific Formula
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Lack of Awareness and Understanding of Clinical Nutrition
      • 3.2.2.2. Shortage of Parenteral Nutrition Products
  • 3.3. Clinical Nutrition Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Clinical Nutrition Market : Product Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Clinical Nutrition Market: By Product, 2018 to 2030
  • 4.5. Oral Clinical Nutrition
    • 4.5.1. Oral Clinical Nutrition Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.6. Enteral Feeding Formulas
    • 4.6.1. Enteral Feeding Formulas Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.6.1.1. Standard Formula
      • 4.6.1.1.1. Standard Formula Market Estimates And Forecasts, 2018- 2030(USD Million)
      • 4.6.1.2. Disease Specific Formula
      • 4.6.1.2.1. Disease Specific Formula Market Estimates And Forecasts, 2018- 2030(USD Million)
  • 4.7. Parenteral Nutrition
    • 4.7.1. Parenteral Nutrition Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.7.1.1. Carbohydrates
      • 4.7.1.1.1. Carbohydrates Market Estimates And Forecasts, 2018- 2030(USD Million)
      • 4.7.1.2. Parenteral Lipid Emulsion
      • 4.7.1.2.1. Parenteral Lipid Emulsion Market Estimates And Forecasts, 2018- 2030(USD Million)
      • 4.7.1.3. Single Dose Amino Acid Solution
      • 4.7.1.3.1. Single Dose Amino Acid Solution Market Estimates And Forecasts, 2018- 2030(USD Million)
      • 4.7.1.4. Trace Elements
      • 4.7.1.4.1. Trace Elements Market Estimates And Forecasts, 2018- 2030(USD Million)
      • 4.7.1.5. Vitamins & Minerals
      • 4.7.1.5.1. Vitamins & Minerals Market Estimates And Forecasts, 2018- 2030(USD Million)

Chapter 5. Clinical Nutrition Market: Indication Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. Indication Market Share Analysis, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Clinical Nutrition Market : By Indication, 2018 to 2030
  • 5.5. Alzheimer's
    • 5.5.1. Alzheimer's Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6. Nutrition Deficiency
    • 5.6.1. Nutrition Deficiency Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.7. Cancer Care
    • 5.7.1. Cancer Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.8. Diabetes
    • 5.8.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.9. Chronic Kidney Disease
    • 5.9.1. Chronic Kidney Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.10. Orphan Disease
    • 5.10.1. Orphan Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.11. Dysphagia
    • 5.11.1. Dysphagia Market Revenue Estimates and Forecasts, 2018 - 2030(USD Billion)
  • 5.12. Pain Management
    • 5.12.1. Pain Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.13. Malabsorption/GI Disorder/Diarrhea
    • 5.13.1. Malabsorption/GI Disorder/Diarrhea Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.14. Others
    • 5.14.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Clinical Nutrition Market: Sales Channel Estimates& Trend Analysis

  • 6.1. Definition and Scope
  • 6.2. Sales Channel Market Share Analysis, 2023 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Clinical Nutrition Market: By Sales Channel, 2018 to 2030
  • 6.5. Online Sales Channel
    • 6.5.1. Online Sales Channel Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Retail Sales Channel
    • 6.6.1. Retail Sales Channel Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.7. Institutional Sales Channel
    • 6.7.1. Institutional Sales Channel Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Clinical Nutrition Market: Regional Estimates & Trend Analysis by Country, Product, Indication, and Sales Channel

  • 7.1. Definition and Scope
  • 7.2. Regional Market Share Analysis, 2023 & 2030
  • 7.3. Regional Market Dashboard
  • 7.4. Regional Market Snapshot
  • 7.5. SWOT Analysis
    • 7.5.1. North America
    • 7.5.2. Europe
    • 7.5.3. Asia Pacific
    • 7.5.4. Latin America
    • 7.5.5. Middle East & Africa
  • 7.6. Clinical Nutrition Market Share, By Region, 2023 & 2030, USD Billion
  • 7.7. North America
    • 7.7.1. North America Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.7.2. U.S.
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Landscape/Reimbursement Scenario
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. U.S. Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.7.3. Canada
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Landscape/Reimbursement Scenario
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Canada Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.8. Europe
    • 7.8.1. Europe Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.2. UK
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. U.K. Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.3. Germany
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Germany Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.4. France
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. France Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.5. Italy
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Italy Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.6. Spain
      • 7.8.6.1. Key Country Dynamics
      • 7.8.6.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.6.3. Competitive Insights
      • 7.8.6.4. Spain Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.7. Sweden
      • 7.8.7.1. Key Country Dynamics
      • 7.8.7.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.7.3. Competitive Insights
      • 7.8.7.4. Sweden Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.8. Denmark
      • 7.8.8.1. Key Country Dynamics
      • 7.8.8.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.8.3. Competitive Insights
      • 7.8.8.4. Denmark Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.9. Norway
      • 7.8.9.1. Key Country Dynamics
      • 7.8.9.2. Regulatory Landscape/Reimbursement Scenario
      • 7.8.9.3. Competitive Insights
      • 7.8.9.4. Norway Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.9. Asia Pacific
    • 7.9.1. Asia Pacific Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.9.2. China
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Regulatory Landscape/Reimbursement Scenario
      • 7.9.2.3. Competitive Insights
      • 7.9.2.4. China Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.9.3. Japan
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Regulatory Landscape/Reimbursement Scenario
      • 7.9.3.3. Competitive Insights
      • 7.9.3.4. Japan Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.9.4. India
      • 7.9.4.1. Key Country Dynamics
      • 7.9.4.2. Regulatory Landscape/Reimbursement Scenario
      • 7.9.4.3. Competitive Insights
      • 7.9.4.4. India Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.9.5. South Korea
      • 7.9.5.1. Key Country Dynamics
      • 7.9.5.2. Regulatory Landscape/Reimbursement Scenario
      • 7.9.5.3. Competitive Insights
      • 7.9.5.4. South Korea Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.9.6. Australia
      • 7.9.6.1. Key Country Dynamics
      • 7.9.6.2. Regulatory Landscape/Reimbursement Scenario
      • 7.9.6.3. Competitive Insights
      • 7.9.6.4. Australia Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.9.7. Thailand
      • 7.9.7.1. Key Country Dynamics
      • 7.9.7.2. Regulatory Landscape/Reimbursement Scenario
      • 7.9.7.3. Competitive Insights
      • 7.9.7.4. Thailand Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.10. Latin America
    • 7.10.1. Latin America Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.10.2. Brazil
      • 7.10.2.1. Key Country Dynamics
      • 7.10.2.2. Regulatory Landscape/Reimbursement Scenario
      • 7.10.2.3. Competitive Insights
      • 7.10.2.4. Brazil Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.10.3. Mexico
      • 7.10.3.1. Key Country Dynamics
      • 7.10.3.2. Regulatory Landscape/Reimbursement Scenario
      • 7.10.3.3. Competitive Insights
      • 7.10.3.4. Mexico Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.10.4. Argentina
      • 7.10.4.1. Key Country Dynamics
      • 7.10.4.2. Regulatory Landscape/Reimbursement Scenario
      • 7.10.4.3. Competitive Insights
      • 7.10.4.4. Argentina Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.11. Middle East and Africa
    • 7.11.1. Middle East and Africa Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.11.2. Saudi Arabia
      • 7.11.2.1. Key Country Dynamics
      • 7.11.2.2. Regulatory Landscape/Reimbursement Scenario
      • 7.11.2.3. Competitive Insights
      • 7.11.2.4. Saudi Arabia Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.11.3. UAE
      • 7.11.3.1. Key Country Dynamics
      • 7.11.3.2. Regulatory Landscape/Reimbursement Scenario
      • 7.11.3.3. Competitive Insights
      • 7.11.3.4. UAE Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.11.4. South Africa
      • 7.11.4.1. Key Country Dynamics
      • 7.11.4.2. Regulatory Landscape/Reimbursement Scenario
      • 7.11.4.3. Competitive Insights
      • 7.11.4.4. South Africa Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.11.5. Kuwait
      • 7.11.5.1. Key Country Dynamics
      • 7.11.5.2. Regulatory Landscape/Reimbursement Scenario
      • 7.11.5.3. Competitive Insights
      • 7.11.5.4. Kuwait Clinical Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Market Share Analysis
  • 8.4. Company Heat Map Analysis
  • 8.5. Strategy Mapping
    • 8.5.1. Expansion
    • 8.5.2. Mergers & Acquisition
    • 8.5.3. Partnerships & Collaborations
    • 8.5.4. New Product Launches
    • 8.5.5. Research And Development
  • 8.6. Company Profiles
    • 8.6.1. Abbott Nutrition
      • 8.6.1.1. Participant's Overview
      • 8.6.1.2. Financial Performance
      • 8.6.1.3. Product Benchmarking
      • 8.6.1.4. Recent Developments
    • 8.6.2. Pfizer Inc.
      • 8.6.2.1. Participant's Overview
      • 8.6.2.2. Financial Performance
      • 8.6.2.3. Product Benchmarking
      • 8.6.2.4. Recent Developments
    • 8.6.3. Bayer AG
      • 8.6.3.1. Participant's Overview
      • 8.6.3.2. Financial Performance
      • 8.6.3.3. Product Benchmarking
      • 8.6.3.4. Recent Developments
    • 8.6.4. Nestle.
      • 8.6.4.1. Participant's Overview
      • 8.6.4.2. Financial Performance
      • 8.6.4.3. Product Benchmarking
      • 8.6.4.4. Recent Developments
    • 8.6.5. Baxter International Inc.
      • 8.6.5.1. Participant's Overview
      • 8.6.5.2. Financial Performance
      • 8.6.5.3. Product Benchmarking
      • 8.6.5.4. Recent Developments
    • 8.6.6. Otsuka Holdings Co., Ltd.
      • 8.6.6.1. Participant's Overview
      • 8.6.6.2. Financial Performance
      • 8.6.6.3. Product Benchmarking
      • 8.6.6.4. Recent Developments
    • 8.6.7. Mead Johnson & Company, LLC
      • 8.6.7.1. Participant's Overview
      • 8.6.7.2. Financial Performance
      • 8.6.7.3. Product Benchmarking
      • 8.6.7.4. Recent Developments
    • 8.6.8. Danone (Nutricia)
      • 8.6.8.1. Participant's Overview
      • 8.6.8.2. Financial Performance
      • 8.6.8.3. Product Benchmarking
      • 8.6.8.4. Recent Developments
    • 8.6.9. Victus, Inc.
      • 8.6.9.1. Participant's Overview
      • 8.6.9.2. Financial Performance
      • 8.6.9.3. Product Benchmarking
      • 8.6.9.4. Recent Developments
    • 8.6.10. Fresenius Kabi
      • 8.6.10.1. Participant's Overview
      • 8.6.10.2. Financial Performance
      • 8.6.10.3. Product Benchmarking
      • 8.6.10.4. Recent Developments
    • 8.6.11. Meiji Holdings. Co., Ltd.
      • 8.6.11.1. Participant's Overview
      • 8.6.11.2. Financial Performance
      • 8.6.11.3. Product Benchmarking
      • 8.6.11.4. Recent Developments
    • 8.6.12. AbbVie (Allergan)
      • 8.6.12.1. Participant's Overview
      • 8.6.12.2. Financial Performance
      • 8.6.12.3. Product Benchmarking
      • 8.6.12.4. Recent Developments
    • 8.6.13. Baxter
      • 8.6.13.1. Participant's Overview
      • 8.6.13.2. Financial Performance
      • 8.6.13.3. Product Benchmarking
      • 8.6.13.4. Recent Developments
    • 8.6.14. Grifols, S.A.
      • 8.6.14.1. Participant's Overview
      • 8.6.14.2. Financial Performance
      • 8.6.14.3. Product Benchmarking
      • 8.6.14.4. Recent Developments